Find Academic Supervisors

• Plant Pathology
• Grapevine Diseases
• Molecular Plant-Microbe Interactions
• +3 more

Julie Chong is a Full Professor at the University of Haute-Alsace (UHA) in Colmar, France, affiliated with the Faculty of Marketing and Agrosciences. She directs the Laboratory of Vine, Biotechnologies and Environment (LVBE) and holds key administrative roles including leadership of the Master 1 'Valorization and Transformation of Agricultural Products' program and the Agronomy pole at UHA. Her academic qualifications include a Habilitation to Supervise Research (2012) from UHA on induced plant defenses in grapevine resistance to cryptogamic diseases, and a PhD in Cellular and Molecular Biology (2001) from the CNRS Institute of Molecular Plant Biology in Strasbourg, where her doctoral research focused on salicylic acid biosynthesis and pathogen-induced glucosyltransferases. Professor Chong's research program investigates molecular mechanisms of grapevine defense against trunk diseases, particularly Botryosphaeria dieback. Her laboratory characterizes defense signaling pathways (notably VvNPR1), studies the role of sugar transporters (SWEET family) in pathogen interactions, and explores resistance sources in wild grapevine species ( Vitis vinifera subsp. sylvestris ). She employs advanced techniques in molecular biology, metabolomics, and pathogen characterization to dissect host-pathogen dynamics and identify sustainable disease control strategies, with emphasis on fungal virulence factors and plant immune responses. Analysis of her 15 most recent publications (2016-2025) reveals consistent focus on effector-triggered immunity, metabolic reprogramming during infection, and biotechnological enhancement of grapevine resilience. Key themes include characterization of fungal secreted proteins, symbiotic interactions with mycorrhizal fungi, and engineering of disease resistance through transporter overexpression, demonstrating translational applications for viticulture. Her scientific contributions have been recognized with: Prime d'Excellence Scientifique (2014) from University of Haute-Alsace Innovative Project Grants from University of Haute-Alsace Professor Chong actively supervises Master's students in the 'Sciences and Technologies of Agriculture, Food and Environment' program, guiding internships and R&D projects. She serves on doctoral committees (EDSC222) and contributes to academic governance as an elected faculty council member. Her research is supported by institutional grants for innovative projects and collaborative initiatives with the regional wine industry. As Director of LVBE, she leads a multidisciplinary team investigating viticultural challenges, maintaining strong connections with the University of Strasbourg doctoral school and Alsace winegrowers to address trunk disease epidemics through integrated molecular and ecological approaches.

Paul KingsleyView profile

Academic

• Embryonic Hematopoiesis
• Erythroid Differentiation
• Ontogeny of Hematopoietic Progenitors
• +3 more

Paul Kingsley, Ph.D. is a Research Assistant Professor (Part-Time) in the Department of Pediatrics, Hematology and Oncology at the University of Rochester School of Medicine and Dentistry. His academic credentials include a Ph.D. and M.S. in Developmental Biology from the University of Rochester (1992, 1987) and a B.A. in Biology from Reed College (1982), followed by a Cancer Center Fellowship in Hematopoiesis at the University of Rochester School of Medicine and Dentistry (1992-1994). Dr. Kingsley's research focuses on: Embryonic Hematopoiesis Erythroid Differentiation Ontogeny of Hematopoietic Progenitors Erythroid Precursor Self Renewal His laboratory employs diverse approaches including subtractive hybridization, degenerate PCR, genechip technology (Affymetrix), and in situ hybridization to investigate blood formation in mammalian embryos. His work examines how hematopoiesis initiates in the yolk sac, migrates to the fetal liver, and finally homes to the bone marrow at the end of gestation. Dr. Kingsley's publication record demonstrates consistent focus on molecular mechanisms of blood cell development, with recent work emphasizing erythroid maturation, hematopoietic stem cell regulation, and chromatin dynamics during erythropoiesis. His research spans from fundamental developmental biology to potential clinical applications in blood disorders and radiation protection. Key research contributions include: Mechanisms of erythroblast enucleation and maturation Regulation of hematopoietic stem cell specification and migration Chromatin remodeling during late-stage erythropoiesis Mitochondrial iron metabolism in heme synthesis Developmental origins of immune cell lineages Effects of radiation on hematopoietic recovery Dr. Kingsley has maintained a productive research career with extensive collaboration, particularly with Dr. James Palis, resulting in numerous high-impact publications in journals such as Nature, Science, Blood, and The EMBO Journal.

• Hematopoiesis
• Developmental Biology
• Imaging Flow Cytometry
• +3 more

Kathleen E. McGrath is a Research Professor in the Department of Pediatrics, Hematology and Oncology at the University of Rochester School of Medicine and Dentistry. She earned her Ph.D. in Biology from the University of Rochester in 1993, an M.S. in Biology from the same institution in 1987, and a B.A. in Biology from Reed College in 1983. Dr. McGrath's research focuses on the emergence and regulation of hematopoiesis in mammalian embryos and its recovery post-radiation. She specializes in imaging flow cytometry for analyzing rare hematopoietic populations and studies erythroid-myeloid progenitors during embryogenesis. Her work intersects developmental biology, hematology, and regenerative medicine. Her recent publications highlight advancements in erythroid self-renewal, megakaryocyte immune roles, and radiation injury recovery. Notable collaborations include contributions to the Palis Lab's investigations into hematopoietic stem cell dynamics and niche interactions. Scientific Awards: Leon Wheeless Innovation in Cytometry Award (2007)

Elizabeth FixmanView profile

Associate Professor

• Immunology
• Respiratory Diseases
• Type 2 Inflammation
• +4 more

Elizabeth Fixman is an Associate Professor in the Department of Medicine at McGill University's Faculty of Medicine and Health Sciences, and a Scientist at the Research Institute of the McGill University Health Centre (RI-MUHC), Glen site. She leads the Translational Research in Respiratory Diseases Program at the Centre for Translational Biology, conducting research at the Meakins-Christie Laboratories. Education BSc in Chemistry/Biochemistry from Colorado State University (1986) PhD in Pharmacology from Johns Hopkins University (1992) Research Focus Dr. Fixman's research employs murine models to investigate innate and adaptive immune coordination in type 2 inflammation within allergic airways disease. Key areas include: IL-33 and RSV activation of lung innate cells, STAT6 pathways in eosinophils, immunomodulatory peptide development (STAT6-IP), and sex hormone influences on inflammatory responses. Her work bridges immunology, respiratory pathophysiology, and therapeutic innovation. Publication Trends Her recent publications (2013-2024) demonstrate consistent focus on STAT6 signaling pathways, sex-based differences in immune responses, dendritic cell migration mechanisms, and novel peptide therapeutics. Research utilizes murine models to explore neonatal immunity, viral reinfection outcomes, and cellular metabolism in immune regulation, with translational applications for asthma and allergic diseases. Teaching and Laboratory She teaches 'Advanced Topics in Respiration' (EXMD 508) and leads a laboratory at the RI-MUHC Glen site investigating immunological mechanisms in respiratory diseases.

David Christopher PooleView profile

Professor

• Oxygen Transport
• Exercise Physiology
• Pulmonary Gas Exchange
• +6 more

Dr. David C. Poole is a University Distinguished Professor of Kinesiology and Physiology at Kansas State University, holding the Elizabeth Chapin Burke Chair in Health and Human Sciences and the Coffman Chair for University Distinguished Teaching Scholars. He serves as Director of the Clarenburg Cardiorespiratory Lab within the College of Veterinary Medicine. His work bridges the fields of kinesiology, physiology, and veterinary medicine, focusing on understanding the fundamental mechanisms of oxygen transport and utilization in health and disease. Dr. Poole earned his B.Sc. from Liverpool Polytechnic and his Ph.D. from UCLA in 1986, followed by a Scientiae Doctor from Liverpool John Moores University in 2000. His academic journey has established him as an internationally recognized researcher in exercise and respiratory physiology. Dr. Poole's research focuses on the critical relationship between oxygen transport and metabolic demands in tissues, particularly during exercise. His laboratory investigates how skeletal muscles can require up to 100-fold more oxygen during exercise compared to rest, and how conditions like heart failure, diabetes, and cancer impair this vital process. Using innovative approaches such as nitrate supplementation and dietary interventions, his work aims to enhance therapeutic strategies for improving exercise tolerance and quality of life in patients with chronic conditions. His research has significantly advanced understanding of capillary function, oxygen uptake kinetics, and Critical Power in exercise physiology. Dr. Poole's extensive publication record includes over 350 peer-reviewed papers in leading journals such as Circulation Research , Journal of Clinical Investigation , and Journal of Applied Physiology . His recent work (2023-2025) demonstrates continued leadership in understanding oxygen transport mechanisms across multiple physiological systems, with particular emphasis on skeletal muscle microcirculation, respiratory muscle function, and the impact of aging and disease on exercise capacity. His research spans fundamental physiological mechanisms to translational applications in clinical settings. Scientiae Doctor from Liverpool John Moores University (2000) Adolph Distinguished Lecturer from the American Physiological Society (2018) Joseph B. Wolffe Memorial Lecture from the American College of Sports Medicine (2021) Higuchi-Dolph Simons Statewide Award for Biomedical Research Excellence (2024) ACSM Citation Award (2019) Fellow of the American College of Sports Medicine Fellow of the American Physiological Society As Principal Investigator, Dr. Poole has secured over $6 million in research funding, with an additional $31 million as Co-Investigator, primarily from the National Institutes of Health and the K-State Johnson Cancer Research Center. His laboratory maintains a vibrant scientific atmosphere with productive collaborations among faculty and students. Key collaborators include Dr. Thomas J. Barstow, Dr. Timothy I. Musch, Dr. Howard H. Erickson, Dr. M. Roger Fedde, Dr. Casey A. Kindig, and Dr. Brad J. Behnke. Dr. Poole's work has achieved an impressive h-index of 84 with over 26,000 citations, reflecting his significant impact on the field. Dr. Poole directs the Clarenburg Cardiorespiratory Lab at Kansas State University, which provides a dynamic research environment focused on understanding oxygen transport limitations from lungs to mitochondria. The lab employs a range of novel and established strategies to investigate tissue oxygenation and metabolic control, with applications to both healthy function and disease states including emphysema, diabetes, chronic heart failure, and cancer.

David T. LodowskiView profile

Assistant Professor

• Structural Biology
• G Protein-Coupled Receptors (GPCRs)
• X-ray Crystallography
• +5 more

David T. Lodowski is an active Assistant Professor at Case Western Reserve University School of Medicine holding multiple appointments across the Department of Nutrition, Center for Proteomics and Bioinformatics, and Department of Pharmacology. He also serves as Director of the Biomedical Sciences Training Program. His laboratory focuses on elucidating the structural mechanisms of G protein-coupled receptors (GPCRs) and related signaling pathways using advanced structural biology techniques. Dr. Lodowski completed his BS in cellular and molecular biology from Tulane University in 1998, followed by a PhD in Biochemistry from the University of Texas at Austin in 2005. He then completed a postdoctoral fellowship in the Palczewski Laboratory at Case Western Reserve University from 2005-2011, where he examined structural changes in bovine rhodopsin during photoactivation and GPCR activation. His research primarily centers on GPCR signaling dynamics, utilizing X-ray crystallography, electron microscopy, and structural mass spectrometry to study macromolecular complexes. Additional research projects include developing biosensors for markers of hypoxia and fatigue, and investigating aquaporins as membrane gas channels. Dr. Lodowski teaches SYBB 501 Systems Biology & Bioinformatics Journal Club and CBIO 455 Molecular Biology I courses. Analysis of his recent publications shows a strong focus on structural biology of membrane proteins, particularly GPCRs and ion channels, with increasing emphasis on protein footprinting techniques and biosensor development. His work bridges structural biology with physiological applications, demonstrating translational potential in understanding cellular signaling pathways. Awards and Honors: Mt. Sinai Scholar (2012) Current Funding: Biosis AFRL as associate project lead since July 15, 2020. Dr. Lodowski has mentored students through the Biomedical Sciences Training Program which he directs. His laboratory has determined numerous protein structures (including IDs 5HI9, 4X1H, 4YEU, and others) related to GPCR signaling pathways. His research team employs a multidisciplinary approach combining structural biology, biophysics, and biochemistry to investigate the molecular mechanisms underlying GPCR activation and signaling, with implications for understanding numerous physiological processes and developing targeted therapeutics.

• Machine Learning
• Deep Learning
• Bioinformatics
• +7 more

Guanghua Xiao is a Professor at the O'Donnell School of Public Health with secondary appointments in the Departments of Bioinformatics and Biomedical Engineering at UT Southwestern Medical Center. His work focuses on developing computational models and algorithms for big data analysis in biomedical contexts, particularly for predicting patient outcomes and treatment responses.

Gail BishopView profile

Professor

• Immunology
• Molecular Biology
• Cell Signaling
• +7 more

Gail Bishop is a Professor of Microbiology and Immunology and Internal Medicine at the University of Iowa College of Medicine. She serves as Associate Director for Basic Science Research at the Holden Comprehensive Cancer Center and holds the Holden Chair of Cancer Biology. Her lab investigates molecular mechanisms of lymphocyte activation, tolerance, and immune cell signaling. Biochemistry Immunology Cell Signaling Cancer Biology Dr. Bishop's research focuses on: TRAF3 regulation of B and T cell survival/activation CD40 signaling in antiviral immunity Immune receptor cross-talk between innate and adaptive systems Mechanisms of TRAF3 tumor suppression Role of TRAF3 loss in autoimmunity and aging Signal transduction pathways in lymphocytes Her recent publications highlight innovations in: T follicular helper cell specification mechanisms TLR signaling regulation in B cells TRAF3-JAK-TCPTP interactions in T cells CD40-mediated innate resistance to RNA viruses Scientific accolades include: AAI Distinguished Fellow (2019) AAAS Fellow (2020) Hubbard-Walder Teaching Excellence Award (2022) Society for Leukocyte Biology Honorary Life Membership (2022) As Editor-in-Chief of The Journal of Immunology (2024-), she continues mentoring trainees through active lab participation and educational leadership. Key collaborations span virology, cancer biology, and immunometabolism research domains.

• Structural Biology
• Biophysics
• Ion Channels
• +4 more

Stephen B. Long, PhD, is a Member of the Structural Biology Program at Memorial Sloan Kettering Cancer Center (MSKCC), where he directs the Cryo-Electron Microscopy Innovation Laboratory and chairs the Oversight Committee. His research employs structural biology and biophysics to investigate ion channels and membrane-embedded enzymes involved in immune function, vision, cell differentiation, and cancer pathogenesis. Education: BA in Physics, Amherst College (1994) PhD in Biochemistry, Duke University (2001) Postdoctoral training, Rockefeller University (2007) Research Focus: Dr. Long's lab studies atomic-level mechanisms of ion channels (e.g., calcium-activated chloride channels, potassium channels) and enzymes (e.g., RAS methyltransferases, Hedgehog acyltransferase). His work bridges structural insights with therapeutic development for cancer and immune disorders, leveraging cryo-EM and biochemical techniques to reveal fundamental principles of membrane protein function. Publication Trends: Recent articles emphasize cryo-EM structures of ion channels (BEST1, TWIK-2, ASOR) and mitochondrial calcium regulators, with consistent themes in gating mechanisms, drug inhibition, and disease relevance. Interdisciplinary approaches integrate biophysics, pharmacology, and cell biology. Awards: Louise and Allston Boyer Young Investigator Award (2016) Burroughs Wellcome Career Award in Biomedical Sciences (2006–2014) Leadership & Training: Dr. Long mentors graduate students and postdoctoral researchers in the Tri-Institutional Chemical Biology PhD Program and Gerstner Sloan Kettering Graduate School. His lab collaborates extensively with clinical and translational teams at MSKCC.

Harel ShouvalView profile

Professor

• Theoretical Neuroscience
• Computational Neuroscience
• Synaptic Plasticity
• +5 more

Harel Shouval is a Professor in the Department of Neurobiology and Anatomy at The University of Texas Health Science Center at Houston (UTHealth) and a Professor in the Electrical and Computer Engineering department at Rice University. His office is located in the McGovern Medical School Building (MSB) 7.264, and he can be reached at 713-500-5708 or harel.shouval@uth.tmc.edu. Dr. Shouval's research focuses on identifying the rules by which changes in synaptic strength—believed to be the basis of learning, memory, and development in the cortex—take place. His work spans multiple levels of analysis, from molecular mechanisms to functional implications, with an emphasis on theoretical and computational approaches. Key areas of investigation include: The molecular basis of synaptic plasticity, including complex simulations of signal transduction pathways and calcium dynamics Development of simplified cellular models of synaptic plasticity, such as his unified calcium-dependent plasticity model The contribution of synaptic plasticity to receptive field development in visual cortex Long-range horizontal connections in visual cortex and their role in map formation The stability mechanisms of long-term synaptic plasticity His extensive publication record demonstrates a consistent focus on computational and theoretical aspects of synaptic plasticity. Dr. Shouval's work bridges molecular neuroscience with systems-level understanding, particularly through his development of the unified calcium-dependent plasticity model that accounts for various induction paradigms including spike time-dependent plasticity. His research shows strong interdisciplinary connections between neuroscience, electrical engineering, and computational modeling, with applications to understanding learning, memory, and developmental processes in neural circuits. Dr. Shouval teaches courses in theoretical neuroscience at both institutions, including 'Theoretical Neuroscience I: Cells, Circuits and Systems' and 'Theoretical Neuroscience II: Learning, Perception and Cognition.' His teaching spans from biophysical foundations of neuronal cells to advanced topics in learning, perception, and cognition, reflecting his integrated approach to neuroscience education. The Shouval Lab for Theoretical Neuroscience maintains an active research program investigating the fundamental mechanisms of synaptic plasticity. The lab has trained numerous graduate students and postdoctoral fellows who have contributed to the field of theoretical neuroscience, as indicated by the 'Former Graduate Students' and 'Former Postdoctoral Fellows' sections on the lab website.

Gordon W. LaurieView profile

Professor

• Cell Biology
• Ocular Biology
• Dry Eye Disease
• +5 more

Gordon W. Laurie is a Professor in the Department of Cell Biology at the University of Virginia School of Medicine. His research focuses on epithelial homeostasis, secretion, and innate defense mechanisms, with particular emphasis on the human prosecretory mitogen 'lacritin' that his lab discovered. Dr. Laurie's work has translational applications for dry eye disease, the most common eye condition, and he co-founded TearSolutions, Inc. in 2013 to advance therapeutic development. Dr. Laurie received his academic training with a BS in Biology from McMaster University MS in Cell Biology from McGill University PhD in Cell Biology from McGill University Dr. Laurie's research program centers on lacritin, a protein critical for ocular surface homeostasis and innate defense. His lab discovered that lacritin and its cleavage-potentiated fragments contribute to tear film stability and exhibit bactericidal properties. Current research directions include identifying lacritin's signaling receptor, exploring its effects on iPSC-derived sensory neurons, investigating its bactericidal activity, and examining potential benefits for pancreatic islet function in type 1 diabetes. His work bridges basic science with clinical applications, particularly for dry eye disease. The publication record demonstrates consistent research productivity with a strong focus on ocular surface biology, lacritin function, and autophagy mechanisms in eye health. Recent work shows increasing clinical translation, including phase 2 clinical trials for dry eye treatment, while maintaining fundamental investigations into molecular mechanisms. Collaborative research with institutions worldwide represents a hallmark of Dr. Laurie's scientific approach. Dr. Laurie organized the multi-institutional Lacritin Consortium in 2002, which has continued to meet biannually with participating institutions including UVa, James Madison University, Eastern Virginia Medical School, Harvard University, University of Illinois at Chicago, Johns Hopkins, UCSF, UC-Berkeley, and the US Army at Fort Belvoir. This collaborative network has been instrumental in advancing understanding of lacritin biology and its therapeutic potential.

Katia Sol-ChurchView profile

Research Professor

• Genomics
• RASopathies
• Cancer Predisposition Syndromes
• +3 more

Katia Sol-Church is a Research Professor of Pathology at the University of Virginia School of Medicine and serves as the Director of the Genome Analysis & Technology Core within the Office of Research Core Administration. Her academic journey began with a Doctoral Degree in Cellular Biology from Université Paul Sabatier (Toulouse, France) and a Ph.D. in Biomedical Sciences from McGill University (Montreal, Canada). Her research spans genomics , RASopathies , and cancer predisposition syndromes , with a focus on applying omics technologies to enhance biomedical research rigor and reproducibility. She has pioneered discoveries in rare genetic disorders like Costello syndrome and Noonan syndrome, often collaborating with institutions such as Nemours and the University of Virginia. Her publication record reveals a trend toward integrating genomic analysis with clinical applications , including studies on coronary artery disease regulatory mechanisms (2022), auditory neuropathy genetics (2021), and RASopathy phenotyping (2017-2019). Collaborations with teams at UVA, Nemours, and international institutions underscore her interdisciplinary approach. As Director of the UVA Genomics Core, she leads initiatives to advance biomedical research infrastructure , emphasizing scientific reproducibility and clinical genomics across departments like Pathology and Pediatrics.

Russell JonesView profile

Professor

• Immunometabolism
• Cancer Metabolism
• Tumor Immunology
• +3 more

Dr. Russell Jones is a Professor and Chair of the Department of Metabolism and Nutritional Programming at Van Andel Research Institute (VAI). His research focuses on cancer metabolism, immunology, and the interplay between cellular metabolism and immune function, with a particular emphasis on understanding how metabolic pathways influence tumor growth and anti-tumor immune responses. Dr. Jones earned his B.Sc. and Ph.D. in Biochemistry and Medical Biophysics from the University of Toronto, followed by postdoctoral training at the University of Pennsylvania. He has held academic positions at McGill University and VARI, where he leads a team investigating immunometabolism and cancer metabolism. His work bridges basic research and clinical translation, aiming to develop novel therapies targeting metabolic vulnerabilities in cancer cells and immune cells. His research interests include tumor immunology, metabolic reprogramming in T cells, and the role of metabolic checkpoints in cancer progression. Notable achievements include discovering mechanisms linking LKB1 mutations to gastrointestinal polyposis and identifying metabolic pathways critical for T cell function in tumor microenvironments. Dr. Jones has been recognized with awards such as the William Dawson Scholar distinction and election to the Royal Society of Canada. He serves on editorial boards of leading journals and actively contributes to clinical trials through collaborations with institutions like VAI-SU2C Epigenetics Dream Team. His laboratory is part of VAI’s Center for Cancer and Cell Biology, emphasizing interdisciplinary approaches to metabolism and nutrition. Current projects explore how metabolic interventions can enhance immunotherapy efficacy and uncover metabolic dependencies in cancer cells.

• Breast Cancer
• Endocrine Therapy Resistance
• Cancer Metastasis
• +4 more

Professor Leonie Young holds a Professorship in the Department of Surgery at the Royal College of Surgeons in Ireland (RCSI), based at York House in Dublin. Her academic career includes roles as Associate Professor (2011–2018) and Professor (2018–present). Her research focuses on uncovering mechanisms of endocrine therapy resistance in breast cancer, particularly involving Steroid Receptor Coactivator (SRC) proteins and metastasis to the brain. She leads the Endocrine Oncology Research Group, leveraging primary patient-derived cell cultures and clinical datasets to identify predictive markers and therapeutic targets. Research Interests: Prof. Young’s work spans breast cancer biology, endocrine resistance, translational oncology, and targeted therapies for metastatic disease. Her group employs high-throughput methods, molecular modeling, and spatial genomics to study SRC-mediated resistance pathways. Current projects include the GeTTMet initiative addressing brain metastasis through genomic adaptations. Grants & Collaborations: She has secured funding from institutions like Science Foundation Ireland, Breast Cancer Ireland, and the EU. Notable grants include the GeTTMet program (2024–2028) targeting brain metastasis via genomic approaches. Her lab collaborates on projects like the OECI Comprehensive Cancer Centre and AICRIstart precision medicine initiatives. Labs & Teams: Leads the Endocrine Oncology Research Group at RCSI, focusing on translational research to bridge molecular insights with clinical applications. The group investigates nuclear receptor interactions, tumor heterogeneity, and novel therapeutic strategies.

Alea MillsView profile

Professor

• Cancer Biology
• Aging
• Epigenetics
• +5 more

Alea Mills is a Professor at Cold Spring Harbor Laboratory, leading the Mills Laboratory and serving as Faculty Head of the Animal Shared Resource within the Cancer Center. She is affiliated with the Cancer Center, the Stanley Institute for Cognitive Genomics, and the Gene Regulation and Inheritance departments. Mills earned her Ph.D. in 1997 from the University of California, Irvine. Her research focuses on the genetic and epigenetic mechanisms underlying cancer, aging, and neurodevelopmental disorders like autism. Central to her work is the study of chromatin regulation and its role in diseases such as glioblastoma, squamous cell carcinoma, and senescence. Key projects include investigating the tumor suppressor gene CHD5, the p63 protein family, and chromatin remodeling complexes in cancer progression. Recent publications highlight advancements in glioblastoma treatment through epigenetic reprogramming, the role of ΔNp63α in cancer stemness, and the impact of chromatin modifiers like BRD8 and EZH2. Mills has also contributed to understanding autism using mouse models of 16p11.2 microdeletion. In 2012, she was honored with the 'Woman of the Year in Health/Medicine' award. Her lab collaborates extensively, with a focus on translating basic research into therapeutic strategies. Current efforts include exploring novel targets for cancer and neurodegenerative diseases, alongside investigating the molecular basis of cellular senescence and aging.